BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17092975)

  • 41. Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25-35) on memory function and hippocampal damage in rat.
    Stepanichev M; Zdobnova I; Zarubenko I; Lazareva N; Gulyaeva NV
    Behav Brain Res; 2006 Dec; 175(2):352-61. PubMed ID: 17070605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine.
    Li SB; Wang HQ; Lin X; Xu J; Xie Y; Yuan QF; Yao ZB
    Chin Med J (Engl); 2005 Apr; 118(8):660-4. PubMed ID: 15899121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
    Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
    J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats.
    Iwasaki K; Egashira N; Hatip-Al-Khatib I; Akiyoshi Y; Arai T; Takagaki Y; Watanabe T; Mishima K; Fujiwara M
    Brain Res; 2006 Jun; 1097(1):216-23. PubMed ID: 16729978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
    Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
    Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.
    Nguyen PT; Kimura T; Ho SA; Tran AH; Ono T; Nishijo H
    Hippocampus; 2007; 17(6):443-55. PubMed ID: 17397046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
    Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
    Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implanted cannula-mediated repetitive administration of Abeta25-35 into the mouse cerebral ventricle effectively impairs spatial working memory.
    Yamada M; Chiba T; Sasabe J; Nawa M; Tajima H; Niikura T; Terashita K; Aiso S; Kita Y; Matsuoka M; Nishimoto I
    Behav Brain Res; 2005 Nov; 164(2):139-46. PubMed ID: 16122819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.
    Alkam T; Nitta A; Mizoguchi H; Saito K; Seshima M; Itoh A; Yamada K; Nabeshima T
    Behav Brain Res; 2008 May; 189(1):100-6. PubMed ID: 18325608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.
    Christensen R; Marcussen AB; Wörtwein G; Knudsen GM; Aznar S
    Exp Neurol; 2008 Mar; 210(1):164-71. PubMed ID: 18053988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation.
    Ostrovskaya RU; Vakhitova YV; Kuzmina USh; Salimgareeva MKh; Zainullina LF; Gudasheva TA; Vakhitov VA; Seredenin SB
    J Biomed Sci; 2014 Aug; 21(1):74. PubMed ID: 25096780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
    Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
    Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
    Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J
    Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The original novel nootropic and neuroprotective agent noopept].
    Ostrovskaia RU; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(5):66-72. PubMed ID: 12596521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
    Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR
    Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of the novel nootropic and neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats].
    Ostrovskaia RU; Tsaplina AP; Vakhitova IuV; Salimgareeva MKh; Iamidanov RS
    Eksp Klin Farmakol; 2010 Jan; 73(1):2-6. PubMed ID: 20184279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
    Sachdeva AK; Chopra K
    J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.